Clinical trial

Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP

NCT00204308

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-03-01

PhasePHASE2

Study timeline

Study start (unknown)2005-03-01Date precision: month

Registry last updated2012-05-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIVunresolved

Pregnancyunresolved

Interventions

Combination tenofovir-emtricitabineDRUG

Sponsors & collaborators

University of North Carolina, Chapel Hilllead sponsor

Elizabeth Glaser Pediatric AIDS Foundationcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00204308 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.